AIR Global has submitted a Premarket Tobacco Product Application (PMTA) to the U.S. FDA for its Crown Switch rechargeable pod vape, aiming to enter the regulated U.S. vaping market. The application includes extensive scientific data on product safety, manufacturing, and consumer behavior, highlighting its potential as an alternative to cigarettes for adult smokers. The FDA's review will determine if Crown Switch can be marketed, marking a key step in AIR's U.S. expansion beyond its shisha brands. This move also targets reducing illicit vaping products by promoting responsible innovation.
AIR Global's Crown Switch vape application provides context for Consumer Staples sector data on Pluang. For readers following Consumer Staples, here is Pluang's market snapshot as of Nov 05, 2026 18:11 WIB: 48 of 63 US stocks rose, 12 fell. Notable movers include XXII at USD 2.18 (-7.18%), SAM at USD 216.15 (-5.33%), and ELF at USD 119.01 (+4.73%).
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
C3is Inc. will implement a one-for-five reverse stock split effective November 9, 2026, reducing its outstanding shares from about 4.2 million to 0.84 million. This move aims to increase the stock price to meet Nasdaq's minimum bid price requirement ...
Firmly secured $15 million in a Series A funding round led by Squarepoint Capital, with participation from J.P. Morgan Payments, Mastercard, and Samsung NEXT. The company provides a no-code platform that connects merchants to AI-driven shopping chann...
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
